Sensitive enzyme immunoassay of antibodies to HIV-1 p17 antigen using indirectly immobilized recombinant p17 for diagnosis of HIV-1 infection.
Recombinant p17 (rp17) antigen of HIV-1 and maltose binding protein-rp17 fusion protein (MBP-rp17) were immobilized onto polystyrene beads in different ways: rp17 and MBP-rp17 were immobilized directly onto polystyrene beads by physical adsorption; biotinyl-rp17 and biotinyl-MBP-rp17 were immobilized indirectly onto streptavidin-coated polystyrene beads; and 2,4-dinitrophenyl (DNP)-MBP-rp17 was immobilized indirectly onto (anti-DNP) IgG-coated polystyrene beads. These directly and indirectly immobilized antigens were incubated with urine samples containing antibody IgG to p17 antigen and subsequently with rp17-beta-D-galactosidase conjugate or (anti-human IgG gamma-chain) Fab'-beta-D-galactosidase conjugate. Beta-D-galactosidase activity bound to the polystyrene beads was assayed by fluorometry. When rp17-beta-D-galactosidase conjugate was used, signals (fluorescence intensities for bound beta-D-galactosidase activity) were much higher with the indirectly immobilized antigens than those with the directly immobilized antigens. By experiments using (anti-human IgG gamma-chain)Fab'-beta-D-galactosidase conjugate, the binding of rp17-beta-D-galactosidase conjugate to antibodies against p17 antigen bound to directly immobilized rp17 antigen was shown to be seriously limited as compared with that to antibodies against p17 antigen bound to indirectly immobilized DNP-MBP-rp17. When rp17-beta-D-galactosidase conjugate and serum samples were used, serum interference was much less with indirectly immobilized DNP-MBP-rp17 than with directly immobilized rp17 antigen, and the sensitivity of enzyme immunoassay for antibody IgG to p17 antigen using indirectly immobilized DNP-MBP-rp17 was 1,000- to 3,000-fold higher than that of enzyme immunoassay using directly immobilized rp17 antigen and Western blotting for p17 band. This sensitive enzyme immunoassay indicated positivity in HIV-1 seroconversion serum panels as early as conventional methods for antibodies to HIV-1 and earlier than Western blotting for p17 band.
Ishikawa
S
S
Department of Biochemistry, Miyazaki Medical College, Kiyotake, Japan.
Hashinaka
K
K
Hashida
S
S
Oka
S
S
Ishikawa
E
E
D019297:2,4-Dinitrophenol; D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis*; D000327:Adsorption; D002352:Carrier Proteins / Q000235:genetics; D015683:Gene Products, gag / Q000235:genetics / Q000276:immunology*; D015483:HIV Antibodies / Q000032:analysis* / Q000097:blood / Q000652:urine; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology*; D006679:HIV Seropositivity; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007140:Immunoglobulin Fab Fragments; D058619:Maltose-Binding Proteins; D011137:Polystyrenes; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D012680:Sensitivity and Specificity; D014764:Viral Proteins; D001616:beta-Galactosidase; D054301:gag Gene Products, Human Immunodeficiency Virus
D002352:Carrier Proteins; D015683:Gene Products, gag; D015483:HIV Antibodies; D015488:HIV Antigens; D007140:Immunoglobulin Fab Fragments; D058619:Maltose-Binding Proteins; D011137:Polystyrenes; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D014764:Viral Proteins; D054301:gag Gene Products, Human Immunodeficiency Virus; C054858:p17 protein, Human Immunodeficiency Virus Type 1; D001616:beta-Galactosidase; D019297:2,4-Dinitrophenol